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IT has been known for some years that when cigarette smoke is condenlsed and
the condensate subsequently dried and stored it forms a " tar "-like substance
which when painted on the backs of certain strains of mice gives rise to epithelial
tumours (literature reviewed by Wynder and Hoffmann, 1964). Among all the
efforts which have been made in recent years to study the carcinogenic properties
of cigarette smoke experimentally, this still remains the salient p)henomenon;
cigarette smoke condensate undoubtedly has the property ofa complete carcinogen
for epithelial tissue of laboratory animals. The fact that dried cigarette smoke
coiidensate possesses this property has led to the beliefthat the agents in cigarette
smoke condensate principally responsible for its mouse skin carcinogenicity are
likely to be stable non-volatile compounds. This belief in turn has formed the
basis for the suggestion by sonme workers (notably Wrynder and Hoffmann (1964))
that reduction of total cigarette smoke condensate and reduction of agents in
the condensate responsible for mouse skin carcinogenicity might be useful steps
to take.
However. up to the end of 1962 when work was started at these laboratories.
little account had been taken of the possible contribution to mouse skin tumori-
genicity of even semi-volatile components of cigarette smoke condensate.
Further, the possibility had not yet been examined that the processes. particularly
of drying, involved in preparing smoke condensate for skin application. miglht
lhave either decreased its tumorigenicity through the destruction of unstable
compounds, or alternatively increased this tumorigenicity by the production of
carcinogens which were not present in freshly prepared condensate. The effect of
storing " tar " for 6 months instead of 1 month had been studied (Wy'nder,
Graham and Croninger 1955), but no work had previously been reported oIn
" tar " less than 1 month old. Neither had an attempt been made by large scale
bioassay techniques to identify the important classes of tumorigenic compounds
in cigarette smoke. In other words it was not known with reasonable certainty,
when the work described in this report was started, whether stable non-volatile
constituents of cigarette smoke condensate were important or trivial contributors
to its mouse skiii tumorigenicity. The general aim of the work to be described
was to investigate this question on a scale sufficient to give reliable answers and to
investigate further the suggestion (Wynder and Hoffmann, 1959; Day, 1961) that
polycyclic aromatic hydrocarbons, or some other neutral constituents, might
account for much of the tumorigenic activity of cigarette smoke condensate.CIGARETTE SMOKE CONDENSATE
It is obvious that the mouse skin painting test is unsuitable for detecting the
effects of constituents with very low boiling points. These are difficult to isolate
and keep in solution in the usual organic solvents at room temperature; it is
impossible to treat mice with very cold materials and in any case the natural body
heat of the animals would lead to rapid loss of material with a very low boiling
point, probably before the skin could absorb it. However, it is possible to com-
pare a condensate containing semi-volatile substances, such as are retained in a
low boiling solvent, with one from which these substances have been evaporated.
Accordingly it was decided to compare the mouse skin tumorigenicity of acetone
solutions of:
(1) Whole cigarette smoke condensate, applied as quickly as possible after
collection while using standard collection traps, hereafter referred to as
" 24-hour condensate ".
(2) Whole cigarette smoke condensate which had been evaporated to constant
weight and stored for at least one month before application, hereafter
referred to as " stored condensate ".
(3) The neutral fraction from whole smoke condensate, after storage for at
least one month.
with
(4) Untreated animals and animals treated with acetone only, kept as controls.
Experiments by previous workers in this fieldhad usedrelatively small numbers
of animals, so that statistical analysis of the results had shown significant
differences only for large effects. It was further recognised that the yields of
tumours from the condensate treatments might be low and that the differences
between the treatments might be small. Accordingly, the present experiment was
conducted on a scale considerably larger than had previously been attempted, and
with a degree ofattention to detail not before attained, in order to be able to make
the necessary quantitative comparisons acceptably precise.
MATERIALS AND METHODS
Experimental design
A maximum response of about 30% of animals developing tumours was
expected at the highest practicable dose. The experiment was therefore planned
to enable a difference between 30% tumour rate and 20% tumour rate to be
detected at the p = 0-02 significance level in four tests out of five. To give some
estimate of the dose-response relationship and to guard against the possibility of
choosing the wrong dose, it was planned to divide those animals treated with
condensates equally between three dose levels with dose ratios 1 : 2 : 4. A total
of about 8000 mice was needed in order to achieve these aims.
Each of the four treatments was divided into three sections. Mice in each of
the three sections of the condensate treatments received different doses; mice in
one section of the control treatment were treated with acetone alone, mice-in the
remaining two sections were untreated. The experiment was housed in four
animal rooms, using mice supplied at different times; each section was equally
represented in each room and in every row of animal boxes in each room. The
difference between animal rooms proved to be important, so for most purposes the
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experiment could be regarded as 40 groups of 165 mice each and four groups of
330 mice.
lice
The mice were virgin females of a specific pathogen-free, albino strain supplied
by Dr. W. G. Davey ofthe Pharmaceuticals Division, Imperial Chemical Industries
Ltd. This strain, as the present paper shows, combined resistance to nicotine
with sensitivity to skin carcinogens. Male mice were not used, being more
pugnacious and so liable to skin damage. The mice. 4-6 weeks old on receipt.
were transferred to sterile boxes and allowed to acclimatise for one month before
skin applications were made. Four groups of 2100 animals, received at intervals
of three months, were used. Of each group, a total of 1980 were used for treat-
ment, 100 for calibration tests with standard carcinogens as described below, and
the remainder for replacement of any animals found to be unsuitable: as for
instance being unduly small or having been injured in transit. Mice were not
replaced after skin treatment had commenced, and treatment was continued until
the animals died or had to be removed due to illness.
Each group of 1980 mice was housed in a separate air-conditioned room, kept
at 20-21° C., the aim being to separate the experiment into four equal units in
order to limit the spread of any adventitious infective disease. In the event. no
epidemic disease occurred and the death rates of the colonies in each of the four
rooms although not identical were similar.
Mice were identified by ear punching and kept on sterile sawdust, three in a
box, in sterilised galvanised iron boxes, being transferred to clean boxes twice a
week. Drinking water in sterile bottles and heat sterilised (30 min. at 630 C.)
Oxoid Breeding Diet pellets were provided ad libitum.
An area 1-5 cm. wide from nape of neck to base of tail of each mouse was kept
clipped. Sesame oil (generally regarded as non-carcinogenic and non-promoting)
was used as clipper lubricant.
l)osing procedure
A preliminary toxicity test of nicotine-containing condensate was undertaken
in order to ascertain the highest practicable dose-level for long-term application.
Dosing by the standard procedure described below was continued for six weeks;
acute toxicity was estimated by observing whether the animals were ill immediately
after dosing, and chronic toxicity by observing whether the animals gained
weight. The results indicated that a top level equivalent to 100 mg. non-volatile
whole smoke condensate (as defined below) per application was suitable, after
habituation, for long-term treatment with acceptably low mortality. Acetone
solutions of test materials, prepared as described later, were therefore applied at
dose levels equivalent to 100, 50 and 25 mg. of non-volatile whole smoke conden-
sate per application, the highest dose level being commenced only afterhabituation
for one month at 75 mg. dose per treatment.
Skin applications were made three times a week, with a foot-controlled
automatic pipette, delivering for all treatments a standard volume of 0 3 ml.
through silicone rubbertubing; pipettes were checked and re-calibrated ifnecessary
daily. The standard volume of fluid was applied evenly on the clipped area.
The reaction to skin carcinogenesis of a sample from every batch of mice
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received at three-monthly intervals was checked by treatment with acetone
solutions (0-1% w/v) of 1,2,5,6-dibenzanthracene and 3,4-benz(a)pyrene, 0-019 ml.
of solution being applied three times per week. Applications to one-half of each
sample of mice was stopped after 10 weeks, treatment of the remainder con-
tinuing for 25 weeks. All these animals developed tumours in a few months, no
great differences being observed between the batches.
Pathology at death and diagnosis of tumours
A full post mortem examination was performed on each mouse, whether bearing
skin tumours or not, and a suitable sized piece oftissue was taken from any organ
showing abnormality. Slides and post mortem descriptions were interpreted by
the same pathologist throughout. All tumours were examined histologically
and their nature recorded, a clear distinction being made between tumours
occurring in the treated area of the skin and elsewhere. A total of 45 animals
were recorded as dying from nicotine poisoning; their records were eliminated
from all results. A summary ofthe pathology recorded at death for the remaining
mice is given in Table I.
TABLE I. Pathology Recorded at Death
All 7875 mice in the experiment (4 x 1980 less 45 deaths due to poisoning)
Per cent of all
Predominarnt pathology mice with this
at time of death p)atholog-y
1. Hepato nephritis 23 (
2. Malignant lymphoma. 22 6
3. Inflammation of uterus and other 12 2
miscellaneous inflammationi
4. Dermatitis and skin sepsis . 8 7
5. Malignant tumours (not on painted 6 7
area and including sarcomas)
6. All haemorrhages 6 7
7. All benign tumours (haemangiomas, 5 0
)aplilloma of painted area and
adenomas other than of lung)
S. Due to experiment (cause not 4-4
determined, etc. but not nicotine
poisoning)
9. Adenoma of lung 36
10. Miscellaneous (general) . 32
11. Malignant tumours on painted aiea 3 O)
12. Staphylococcal osteomyelitis 0 9
Apart from skin sepsis, which was more common in the high dose groups, the
pathology was not particularly related to treatment and the incidence of tumours,
other than those of the painted area, did not vary significantly with dose or
treatment. Any animal considered at any time by the animal superintendent to
be irrecoverably ill was killed, as were mice which escaped from their boxes.
For cancers of the skin in the treated area, particular attention was paid to
making the diagnosis ofmalignancy independent of subjective factors. The strict
criterion of malignancy adopted was penetration by the epidermal tumour be-
tween the muscle fibres of the panniculus carnosus (" muscle-infiltrating carci-
noma") as shown in Fig. 1. Tumours which had the subjective appearance ofT. D. DAY
infiltrating caincer but which did not fulfil this strict criterion of muscle penetra-
tion were separately classified (" carcinoma not infiltrating muscle "). The rare
occurrence of a subcutaneous sarcoma or haemangiendothelioma in the treated
area was also noted.
The date offirst appearance ofa papilloma was noted on a record card, kept for
each animal throughout the experiment. Tumour-bearing animals were normally
killed when the tumour appeared to have become malignant, as judged by the
pathologist pinching up the skin and assessing the degree of infiltration on its
under surface. The date of death was then recorded as the date of appearance of
a carcinoma, if one was found by histology.
Cigarettes
Plain cigarettes (length 70 mm., circumference 25-3 mm., average weight
1 125 g.) were specially manufactured from a composite blend of flue-cured
tobacco representing the major plain cigarette brands smoked in the United
Kingdom, packed in batches of 50 in vacuum-sealed tins and stored at 40 (1.
before use.
ASmokingj procedure
The automatic smoking machine used operates by coninecting each of 24
cigarettes, secured in holders situated round a revolving disc, in turn to a source
of vacuum, the unlighted end ofeach cigarette being open to atmosphere between
puffs (Fig. 2). Cigarettes were lighted by an electrically heated coil. When
individual cigarettes had reached an estimated butt length of 20 mm., the butts
were removed and replaced with fresh cigarettes.
Automatic smoking constants were chosen to simulate the manner used by the
average cigarette smoker in the United Kingdom (Bentley and Burgan, 1961):
Puff volume, 25 ml.; Puff duration, 2 seconds;
Puff interval, 1 minute; Butt length, 20 mm.
Whole smoke condensate (WSC)
Cigarette smoke was collected in four glass traps connected in series (Fig. 3),
cooled in acetone/crushed solid carbon dioxide. Traps 3 and 4 each contained
glass helices (100 g., 4 mm. diam. single turn). On completion of smoking, traps
were allowed to attain room temperature, condensed smoke was washed from the
traps and connecting tubes with acet6ne (about 900 ml.), the washings filtered
through glass wool and an aliquot of the combined filtrate taken to check non-
volatile whole smoke yield by determination of nicotine. The average yield of
nicotine was 1-61 mg./cigarette, range 1 30-191 mg./cigarette.
EXPLANATION OF PLATES
FIG. la.-IMalignant infiltration of the subcutaneous tissue by epidermal cancer cells, but
these have not yet lenetrated the muscle. H. and E. x 80.
FiG. lb. Epidermal cancer cells which have infiltrated between the fibres of the lpanniculus
carnosus muscle. This is the uisual criterion for the diagnosis of malignancy. H and E.
x 190.
FIG. 2. Smoking machine.
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FIG. 3a.-Smoke condensation system. The arrow on the right shows the exit to the smoking
machine, via a cotton wool filter. The two right hand traps contain Fenske helices (single
turn 4 mm. diam.) and all four Dewar flasks are filled with solid carbon dioxide and acetone.
,Non-volatile whole smoke condensate (NVWSC)
Solvent was removed from the acetone solution of WSC in a weighed flask,
using a rotary evaporator on a boiling water bath with a water suction pump
operating at a vacuum of 10 inches of mercury; evaporation was continued until
the non-volatile residue attained constant weight. The average yield was 215
mg./cigarette, range of 17-7-24'8 mg./cigarette. All doses ofall materials applied
to animals were expressed in terms of the weight of NVWSC determined in this
way, each individual dose, irrespective ofweight, being delivered in the standard
volume (0.3 ml.) of solution. The average yield of NVWSC over a four-week
period was used to compute the number of cigarettes to be smoked for both 24-
hour condensate solutions and for the stored condensate and neutral fraction
required during the subsequent four-week period.
Stored condensate
NVWSC collected over four weeks was combined, stored at -29° C. for a
further four weeks, dissolved with constant stirring in acetone/water (9: 1 v/v)
and the solution diluted to the appropriate volume with the same solvent.
24-hour condensate
The acetone solution of WSC from the calculated number of cigarettes was
sampled for nicotine content to check the actual WSC yield and concentrated in a
rotary evaporator (water bath temperature 400 C. and the full vacuum of a water
suction pump), until it reached the concentration required for application at the
highest dose rate. Aliquots ofthe concentrate were then taken for dilution with
acetone/water (9: 1 v/v) to provide solutions for the two lower dose levels.
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Neutralfraction
Redistilled peroxide-free Reagent Grade diethyl ether was treated with sodium
to remove fluorescent material. The smoke condensate from a known number of
cigarettes (about 2000) was washed from the traps into a separating funnel with
ether (1 1.) and hydrochloric acid (" Analar " 2 N, 900 ml.), the mixture was
shaken, allowed to separate and the aqueous layer drawn offinto a second separat-
ing funnel. After further extractions withl hydrochloric acid (2 x 200 ml.,CIGARETTE SMOKE CONDENSATE
5 x 100 ml.), the combined acid extracts were washed with ether (2 x 100 ml.),
and the ether washings returned to the ether solution left in the first separating
funnel. The combined ether solution was then vigorously shaken with potassium
hydroxide solution (300 w/v, 200 ml.), allowed to stand for 1I hours, the aqueous
layer drawn off and further extractions carried out with potassium hydroxide
solution (1 X 200 ml., 5 x 100 ml.); little emulsification occurred after the first
extraction and the two layers separated without difficulty. The final ether
solution was dried (anhydrous magnesium sulphate), filtered and the solvent
removed in a rotary evaporator (water bath at 40° C. and a water suction pump)
The average yield of neutral fraction was 6-68 mg./cigarette, range of
5-00-788 mg./cigarette; the condensate yield of each batch was checked by
estimating the nicotine content ofa suitable aliquot ofthe combined acid extracts.
Batches ofneutral fraction produced in a four-week period were combined and the
corresponding NVWSC equivalent calculated from the total number of cigarettes
smoked and the average yield of NVWSC obtained for stored smoke condensate
over that period of four weeks. For dosing, the combined neutral fraction was
dissolved in acetone/water (9: 1 v/v).
Nicotine assay
Nicotine content was measured on aliquots of the condensate obtained from
every individual smoking, to check on smoking performance and extraction
efficiency, by the method of Willits, Swain and Connelly (1950), as modified by
Laurene and Harrell (1958).
DISCUSSION OF RESULTS
Table II shows for all animals the percentage rates (100 x No. affected/Initial
No.) for death and incidence of three classes of tumours at four times during the
experiment. No allowance has been made in these results for differences in
mortality between treatments, and it can be seen that there are quite large
variations in mortality from one treatment to another. To give a fair comparison
ofthe treatments, independent of their toxicity, some form of age standardisation
must be done on the assumption (which seems unavoidable in experiments of this
type) that animals which develop tumours would not, in the absence oftreatment,
have lived longer or died sooner than the others. The age standardised results,
calculated in the way described in the Appendix are shown in Table III.
In order to attain the objectives outlined earlier, it was necessary to discover
if the data would permit a valid comparison to be made of the tumorigenicities of
the three materials under test. It was not the intention in planning the experi-
ment to investigate the mechanisms of carcinogenesis, for example the relative
contributions in each material from tumour initiators and tumour promoters,
but unless the three materials act in broadly similar ways there can be no valid
basis for comparing their relative tumorigenicities. Graphical representation of
the data, exemplified by Fig. 4, 5 and 6, in which no account is taken of the
statistical confidence limits of the points, suggested an anomaly in that at the low
and medium dose levels stored condensate and neutral fraction appeared to have
similar activities, each different from 24-hour condensate, whereas at the high
dose level stored condensate and 24-hour condensate appeared to have similar
activities, each different from neutral fraction. The statistical analysis, which is
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FIG. 4.--Dose Response Graphs, Unstandardised. 128 Weeks. Upper: All Tumours.
Lower: Infiltrating Carcinomas.
Neutral Fraction
Stored Condensate
24 Hour Condensate
Doses measured in mg. F A S per application
described in the Appendix, showed that the response curves for every group of
animals could be fitted by a lognormal distribution over time of the tumorigenic
force, which is defined as the number of new tumour-bearing animals found in a
short period divided by the number oftumourless animals alive in the group at the
start of the period. This distribution has three parameters, its standard devia-
tion, which was found to be unaffected by treatment or dose, the proportion of
animals which would neverdevelop tumours however longthey lived, and the mean
ofthe distribution, which measures the average time from the start oftreatment to
the appearance of a tumour (the mean tumour-induction time). These last two
parameters were found to be highly correlated, long tumour-induction times
appearing with large proportion never developing tumours, so that either can be
used as a measure of response to the treatment. With the three condensates
used in this experiment the mean tumour-induction time falls by about 25% when
the dose is doubled, over the range ofdoses used, and this relationship can be used
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to relate the differences between condensates to the change in dose which would
FI.be needed to give equal r-Response Graphs, Agin the same way as in a toxicity bioassay.
Table IV shows the relrative tumorigenicities calculated frinom the mean tumour-
inducNeut rtion r never developing tumours, and also the values
calculatefrmhstn oredrCondens.t Thes lte v ated
24because they contain the statistically significant anomaly in the stored condensate
results (described fully in the Appendix) which was not apparent in the mean
tumoDoses measur-induced in mg. F A S pertion times.
The first differenes between ondens atehis toable is the uncertangeinty in the relative
be needed togiveequal responses, in the same way as in atoxicitybioassay.
Table IV shows the relative tumorigenicity even working with a total of 8000 mice. For example, the meratiour-
indfor 24-hour ctiondensate and neutral fraction evat the 95 confidence limit, valies
somewhcalculated from the standar 2ds1. This illustrates strikingly how difficult quanti-ed
becausethey contain thestatisticallysignificantanomaly in the stored condensate
results (described fully in the Appendix) which was not apparent in the mean
tumour-induction times.
The first important feature of this table is the uncertainty in tile relative
tumorigenicity even working with a total of 8000 mice. For example, the ratio
for 24-hour condensate and neutral fraction at the. 95% confidence limit, lies
.somewhere between 1.5 and 2.1. This illustrates strikingly how difficult quanti-
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tative work is in this field and it may be noted that had the experiment been
carried out on only about 1/12 of this scale with 50 animals on each dose level, or
600 in the whole experiment, then the rates of tumorigenicity for 24-hour con-
densate and neutral fraction would have had confidence limits of at least 1 0 to
3-0 at the 95% level.
Within the limits used the tumorigenicity of each material increased linearly
with the log dose so that even at the highest dose used there was no evidence that
the point of saturation of the tumorigenic action was near. Not unexpectedly, the mean tumour-induction times for carcinomas and non-infiltrating carcinomas
were longer than those for all tumours but it is of considerable interest that the
relative tumorigenicities of 24-hour condensate, stored condensate and neutral
0T. D. DAY
TABLE IV.-Relative Tumorigenicities
From all tumours, all carcinomas and infiltrating carcinomas combined.
From mean tumour-induction
times and proportions of
animals never with tumours
Denom.
Dose
levels
25, 50 . Neutral )
fract.
100 .J
25, 50 . Stored
cond.
100 J
Neutral Stored 24-hour Neutral
fract. cond. cond. fract.
From standardised tumour
rates at 128 weeks
Stored
cond.
24-hour
cond.
r I 0-89+
1 110 1-77 20+%-16% 1-88+
L1 2-06± 4 16%-13% 28%0-222oJ
K 1 l 940/+
. .1 1 *59 . 20%-16%
- 1 1-06+
26%-22%
Symmetric conf. limits p = 0 -95
are + 15%- 11% of the ratio
The % figures are symmetric
conf. limits p = 0-95
fraction were found to be in the same ratio using in turn each ofthese three tumour
types, as can be seen from Table V. This suggests that the three condensates act
in broadly the same way on the test animal and that the relative tumorigenicities
which we have given do refer to intrinsic properties of these condensates.
TABLE V.-Relative Tumorigenicity
From mean tumour-induction times
Stored/Neutral .
24-hour/Neutral .
24-hour/Stored
95% Conf. lim. .
(equal tails)
All tumours
1-07
1-67
1-56
+29%-21%
As stated earlier, it had often been surmised that non-volatile neutral com-
ponents of cigarette smoke are responsible for the tumorigenicity of the smoke
condensate, but until the present experiments it could only be considered as an
inspired guess. Our results, using 9500 one tail confidence limits, suggest that
non-volatile neutral components account for something more than 5000 of the
tumorigenicity of 24-hour cigarette smoke condensate, and 80% of that of stored
cigarette smoke condensate as defined in this report. It then follows that the
compounds responsible for this effect are stable after collection for several weeks
and are not affected by moderate heat treatment and chemical manipulation. It
is unlikely that they are produced as artifacts in the process of making stored
condensate.
The results certainly suggest that 24-hour condensate is more tumorigenic than
stored condensate. While neither material contains what is usually termed the
volatile fraction, there must be substances in 24-hour condensate which are lost or
modified when evaporation is carried out to dryness; chemical analyses of these
condensates are however not informative because at this stage we do not know to
which of the large number of constituents attention should be directed. The
Carcinomas
1-08
1-63
1-50
+67% -36%
Infiltrating
carcinomas
1-15
1- 69
1 47
+750%-37%o
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results provide no evidence to decide whether any part of the activity of 24-hour
condensate is due to its processing or storage.
In practical terms, an important feature of these results seems to be that in
relation to mouse skin they show that there are stable non-volatile neutral carci-
nogens in cigarette smoke condensate which are worth serious attention and which
in particular merit investigation by detailed fractionation.
SUMMARY
The mouse-skin carcinogenicity offreshly prepared cigarette smoke condensate
was compared at equivalent dose rates with that of a condensate which had been
evaporated to constant weight on a boiling water bath and subsequently kept for
several weeks, and with that of a neutral fraction of the condensate. The carci-
nogenicity in terms of several different response measures was linearly related to
the logarithm of the dose, and the response to the three different materials was
broadly similar, the freshly prepared condensate being more active than the other
two materials used.
The results provide evidence that non-volatile neutral components of cigarette
smoke contribute substantially to the mouse skin carcinogenicity ofwhole 24-hour
old cigarette smoke condensate, as defined in this report and, for the first time,
that the compounds responsible for this effect are stable from 24 hours after
collection for several weeks, and that these compounds were not produced as
artifacts in the processing leading to stored condensate. The substances respon-
sible for the additional carcinogenicity of 24-hour old condensate have not been
identified.
I should like to thank the scientists of member companies of the Tobacco
Research Council for their advice and help in this experiment, and particularly
Mr. W. S. Paige for suggesting and carrying out the statistical analyses in this
report and for preparing the statistical Appendix. The experiment also owes
much to Mr. T. Smith who was responsible for the preparation of the condensates,
to Mr. D. V. D. Thorowgood who was responsible for the animal husbandry, and
to those many junior technicians whose efforts have made this work possible.
APPENDIX
STATISTICAL CONSIDERATIONS
W. S. PAIGE
Several techniques are described in the literatuire for the analysis of mouse
tumour experiments. The earliest is due to Twort and Twort (1933) who used
three methods. The first two depend upon comparisons ofcumulative percentages
of tumours with a standard curve, and the third estimates the time at which 25%
ofthe animals would have developed tumours, in the absence ofmortality, using a
crude approximation to the tumour expectation of animals which died during the
experiment. Irwin and Goodman (1946) compared these measures with the
standard actuarial calculations, which were also used by Palmes, Orris and Nelson
(1962) and Blanding et al. (1951) and recommended the use of expectation of
tumourless life, when there is no mortality, as the most clearly interpretable
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measure. In our terms this is the mean tumour induction time. They considered
that the date at which a particular tumour rate was reached was not in general a
useful measure of response.
Bryan and Shimkin (1941) described the application of standard bioassay
techniques to this problem, but they were concerned mainly with potent carci-
nogens and did not use efficient techniques for comparison in the presence of
natural mortality. They also gave analyses oftumour-induction times (under the
name " latent period ") showing that in some cases they were independent ofdose.
They advocated the use of the ED50, the dose which produced 5000 response, for
the comparison of different treatments; and suggested that the mean tumour
induction time for this dose was a useful parameter. Their formula for the time
at which an experiment could be safely terminated shows the necessity of con-
tinuing experiments with weak carcinogens until all the animals are dead. Lea
(1945) criticised this paper by Bryan and Shimkin for its lack of emphasis on
techniques for eliminating differences in mortality. He suggested, for experiments
with continued or persistent treatments, a maximum likelihood procedure for
estimating a lognormal distribution over time of the tumorigenic force, which
made full allowance for mortality. This method, however, suffered from the
disadvantage that it assumed that all animals would develop tumours ifthey lived
indefinitely, which does not seem to be justified with control groups or weak
carcinogens.
Blanding et al. (1951) described a technique in which an effective tumour rate is
plotted on log probability paper to estimate the time at which the rate will be 50%.
This effective rate is the number of animals which have borne tumours divided by
the original number less deaths without tumours. This rate is neither an un-
corrected rate nor a standardised rate, and it is difficult to use in any theoretical
model of tumour incidence. They also recommend the use of a tumour potency
the reciprocal of the time-to-50 -rate, but this does not seem nearly as suitable
a measure as the equivalent dose considered below for use with large experiments
on weak carcinogens, since it depends on the stability of the animal population
used, and its variance depends upon the mean.
WTynder (for example, Wynder and Hoffmann, 1959) and other workers have
used the number of tumours or the number of tumour-bearing animals at a parti-
cular date to compare treatments; but this method is open to objections. as
described below, if the different treatments have different mortality rates. How-
ever, this approach was used as the starting point in an attempt to develop an
improved analysis.
ANALYSIS OF RATES
A number of different analyses have been done on our data, but they fall into
two main types: the first deals with " tumour rates " defined as the number of
tumour-bearing animals observed to date in a group divided by the number of
animals in the group at the start of treatment. This is a cumulative measure
which smooths out statistical fluctuations, but causes difficulties when independent
statistical tests are needed for results at different stages of the experiment. The
second group ofanalyses deals with the " tumorigenic force " defined as the number
of new tumour-bearing animals observed in a group during a short time interval
divided by the number oftumourless animals alive in the group at the start ofthat
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interval. The observations for different intervals are here uncorrelated, but
suffer from large statistical fluctuations.
The simplest analysis which can be done is a comparison of the tumour rates
at a given time for groups of animals under different treatments. In the case of
toxic treatments (and 24-hour smoke condensate is somewhat toxic in the doses
used in this experiment, since the mortality from all causes is higher under this
treatment) there are two courses open. Firstly, the number oftumourswhich was
actually observed can be used as it stands. If this is done a treatment which is
toxic but has the same capacity for producing tumours as a non-toxic treatment
will show a smaller number of tumours than the non-toxic treatment because the
number of animals at risk at any time will be smaller if some have been poisoned.
Alternatively, it can be assumed that the poisoned animals were a random sample
of the whole. Then some form of correction can be applied for the varying
mortalities to give standardised numbers of tumours and an analysis can be done
of the response excluding the toxic effect. In order to do age standardisation by
any technique it is necessary to assume that the expectation of life for those animals
which develop tumours would, in the absence of treatment, be the same as that of
the remainder of the group. This assumption is basic also in the analysis of
tumorigenic force, since the denominators in all the fractions, for different treat-
ments and for different times, must be comparable.
Detailed analyses of tumour rates and death rates were carried out at 24-week
intervals from 56 weeks to 128 weeks from the start of treatment. Table II above
shows, for all four rooms taken together, the average un-standardised rates at the
four selected times, and Fig. 4 shows the results for 128 weeks graphically. Table
III and Fig. 5 show corresponding age standardised rates. The age standardisa-
tion used the direct method (Yule, 1934), taking as its standard population the
mean mortality curve for all animals in the experiment, which reduces the correc-
tions needed almost to the minimum possible. For each week in turn the age-
specific rate for a group of animals was applied to the proportion surviving of the
standard population and these results were accumulated to give a standardised
rate up to a given age for that group. To show the magnitude ofthese corrections
the standardised death rates are also shown. In a group with greater than
average mortality the standardised mortality will of course exceed 1 towards the
end ofthe experiment. It was hoped originally to calculate mean tumour-induction
period by the acturial method (Irwin and Goodman, 1946; Blanding et al., 1951)
but the observed rates were all well below 5000 so the extrapolation involved
made the results unreliable.
A preliminary analysis of deaths showed that as well as differences between the
treatments there were several anomalies in the mortality curves for different
animal rooms. This is shown in Table VI, which records the cumulative numbers
of deaths. The most significant feature is the excess of deaths in Room 2 about
week 70. This was due to animals being killed in Room 2 at that time on account
of a number of different types of pathology, following a change in the standard
of illness applied as a criterion for removal of animals. Similar but much smaller
anomalies were found in other rooms at other stages in the experiment but no
significant anomalies were found between groups of mice in a room. It was
therefore necessary to keep the four animal rooms separate throughout the analysis
(though the tables presented here give results for all four rooms together for
brevitv).
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TABLE VI.-C(umulative Number of Deaths (All Treatments)
Room
Treatment A
Week 1 2 3 4
56 512 537 531 551
72 944 1134 973 1000
88 . 1464 1589 1522 1501
104 1833 1890 1381 1851
Since there are anomalies in rates between the animal rooms, and because the
corrections involved in standardising were quite large (as inspection of Table III
shows) significance tests between treatments based upon binomial distribution
theory, including the x2 test, are invalid. Analysis of variance, however, does not
depend upon the exact fit of the data to particular distributions, and is robust
under deviation from distribution assumptions, so it can validly be applied to
either the standardised or the unstandardised data.
ANALYSIS OF VARIANCE
A preliminary inspection showed that the control groups, having few or no
tumours, gave different variations between rooms from the treated groups. The
analysis of variance was therefore split into two parts:
A Controls Two types of control (untreated and acetone treated ) x 4 rooms.
1B Treated 9 treatments x 4 rooms. The 9 treatments were further divided into
3 types of condensate x 3 doses, the dose relationship being expressed
as linear and quadratic terms. The between-rooms term, with 3
degrees of freedom, was subtracted from the residual as a "block
effect ".
A specimen analysis of variance is shown in Table VII.
TABLE VII. Analysis of Variance Sin-1 (SQRT (R))
R=standardised rate, all tumours 104 weeks.
Source df SS X 104 Mean square x 104 F
Total . 43 25055 . 583
Betwean controls 1 393 393 2-53
Within controls 6 . 93-1 15.5 1
Control-treated 1 93892 . 9389 2 ---
Dose linear 1 10712 . 10712 436
Dose quadratic 1 87-3 87-3 3-55
Condensates . 2 . 2312 . 1156 47-0
Dose x cond.. 4 1064 266 10-8
Within treat.. 24 . 591 246 100
Rooms . . 3 767 2556 104
Analysis of variance cannot be done directlv on the rates, since their variaince
depends upon the mean; the results must be transformed. The usual transforma-
tion for rates (Bartlett, 1947) is the inverse sine of the square root of the rate; but
since ratios were required an analysis of the log rates was also done. The square
root transformation appropriate for Poisson data was tried on some sets of results
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with no rates above 10%. These analyses showed little difference from the inverse
sine results and were used only to confirm the findings.
The most striking feature of Table VII is the extreme linearity of the dose
effect. In 24 analyses (4 times x 3 tumours x standardised or not) only four
quadratic terms (for all tumours, 56 and 104 weeks) were significant at the
p = 0-05 level.
The other features of the analysis are shown best by the table of means, and
that corresponding to Table VII is shown in Table VIII. As would be expected
from Table VI, the difference between rooms is attributable to Room 2.
TABLE VIII.-Meansfrom Analysis of Variance Sin-' (SQRT (R))
R = standardised rate, all tumours 104 weeks
Controls: Untreated Acetone
0-119 . 0075 . C.L. 0-048
Treatments:
Dose Low Med. High Mean
Neutral fraction . 0248 . 0396 . 0548 0 397
Stored condensate . 0228 . 0347 . 0756 0444
24-hour condensate 0350 . 0-618 . 0789 0586
Mean . 0275 . 0454 . 0698 0476
C.L. individuals 0-049 row col. means 0-028
C.L. p = 0 95
Room 1 2 3 4
0 442 . 0555 . 0-461 . 0445 C.L. 0 032
C.L. p 0
- 95 denotes confidence limits at 95% level.
The interaction of Dose and Condensate is seen to be mainly due to the high
dose treatment of stored condensate. The two lower doses show responses very
similar to neutral fraction, while the high dose response is considerably higher
than that for neutral fraction. This pattern is visible in all the analyses. It has
been called the stored condensate anomaly.
There is a corresponding effect, in the opposite sense, in 24-hour condensate,
where the top dose response is markedly low. This is not significant in many of
the standardised analyses, but it is very significant in the unstandardised tables.
It is thought that this is due to the toxic effect oflarge doses of24-hour condensate.
Table IX summarises these effects in a number of analyses of variance in
columns giving the dose effect, expressed as the increase in response for doubled
dose, the differences between condensates, the difference between treated and
control and the stored condensate anomaly expressed as difference observed-
expected on linear increase. A few values are given for the log analysis, but this
was little use for the carcinoma results since it is unsatisfactory with counts below
about 5 individuals.
The great difficulty with the results in Table IX is to find some way of com-
bining data for different times. It was clear from these results, however, that the
response differences, on all the scales tried, varied with time, and it would be
necessary to use the dose-response relationship to convert differences back into
equivalent dose ratios.
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Since the linear relationship between the logarithm of dose and the response is
then of great importance in interpretation of the results, an entirely different
analysis, based upon the tumorigenic force, was done to check it.
ANALYSIS OF TUTMORIGENIC FORCE
Individual periods must be combined for this purpose in order to reduce the
random variations, and a method offitting standard statistical distributions to the
tumorigenic force was used. This method is a generalisation of that used by Lea
(1945) and approximated by Blanding et al. (1951) and it fits a lognormal distribu-
tion (with mean log tumour-induction time m, standard deviation s) to the tumori-
genic force, using the method of maximum likelihood. The generalisation allows
a proportion c ofthe animals to remain tumourless indefinitely. This method was
devised by Boag (1948, 1949) for examination of radiotherapy success in human
cancer. Assuming that the distribution over time of the tumorigenic force in a
given group of animals has either normal or lognormal form, it is then possible to
write down the likelihood function for the observed data:
L K+ 4 E In (1c)z + EI (c +(I1- c)q)
Group Group
1 .,
in which
t or ln(t) -n
s s
for the two alternative forms
00
z 1/ e-5x2 and ( fzdx
x
where L is the log likelihood, t the timne, mn the mean of the distribution, s its
standard deviation and c the proportion of animals which would never develop
tumours in the absence of natural mortality.
The summation over Group 1 covers all animals which develop tumours (tumour
developing at time t) and that over Group 2 all animals which die tumourless
(at time t).
The values of mn, s, c which maximise L can be found either by equating partial
differential coefficients to zero in the usual way (as was done by Boag) or by using
a maximum seeking procedure such as Nelder's simplex method (Nelder and Mead.
1965). ComputerprogramwritteninAlgols areavailableforthe lattertechnique.
The assumptions made about the form of the distribution of tumour incidence
can then be rigorously tested by x2 goodness of fit tests. The distribution para-
meters will contain the information about difference between treatments, and
analyses can be done on them.
This model has two great advantages over methods using rates. The distribu-
tion of tumours over time is defined as a distribution of tumorigenic force, which
makes it possible to eliminate from the equations the mortality of the various
groups of animals, and get satisfactory comparisons even of toxic treatments.
This is, of course, the object of age standardised rates, but the fitted model over-
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comes the great disadvantage of age standardisation: that in treatments with
excess mortality a single tumour may, in the standardised results, be weighed up
to 4 or 5 and in a treatment with less than normal mortality it may count only
02 or 0 3. The maximum likelihood equations give each observation the weight
needed to maximise the precision of the estimate; no difficulties are encountered
when comparing treatment responses with different treatment-associated mortality
rates nor any difficulties associated with selecting arbitrary time segments in the
experiments.
Goodness of fit tests were done on the lognormal distributions fitted, and the
values of%2 are shown in Table X. In Room 2 there are four significant values, but
inspection of the data shows that all four are local anomalies between weeks 65
and 75, which are due to the change mentioned above in the standards ofreporting
illness and tumours. Since these results were so local it was not thought worth-
while to censor or attempt to smooth the data to eliminate them. One similar,
though smaller anomaly was found in one treatment of Room 3. To give a
more sensitive test of the fit of the model X2 tests were done on the sum of all
treatments in each animal room. These were all very significant but the general
picture was the same, with large local anomalies. The deviations in the four
animal rooms were quite different, and a test on all four rooms taken together
though still significant, showed smaller individual X21S. As a further check that
these anomalies were local, and not due to a badly fitting model, normal distribu-
tions of tumorigenic force were fitted: and both individual treatment x2 tests and
an overall x2 test were done. The results ofthese tests were almost identical with
those of the lognormal tests, helping to confirm the local variation hypothesis.
Analyses of the normal distributions were done, but it was found that the
standard deviation ofthe distributions increased with the means; and the patterns
of variation between doses and treatments were less clear than those shown by the
lognormal distributions, so the normal distribution results are not given in detail.
TABLE X.-Goodness ofFit Lognormal Model Tumours
Treatment Room 1 Room 2 Room 3 Room 4
No. df X2 df x2 df x2 df x2
1 Control 1 0 02 2 0 92 1 0 25 . 2 0 80
2 Control acet. . 1 0 00 1 0-38. 1 0-06 . 1 0 35
3 Neutrallow 3 2-48 . 3 2 -33 2 0 67 4 1-10
4 Neutralmed. 4 3-41 . 5 2-33 6 5-38 6 4-79
5 Neutralhigh 8 12-65 . 9 25-01 . 9 8-40 . 8 8-60
6 Storedlow 1 1-01 3 1-79 . 3 4-28 2 0-10
7 Storedmed. 6 7-32 7 14-51 . 4 2-98 . 4 1-57
8 Storedhigh 12 12-99 . 11 17-01 12 23-82 . 12 10 99
9 24-hourlow . 5 1-28 . 7 4-66 6 5-88 . 4 1-00
10 24-hourmed. . 11 18- 18 11 35-19 9 9-23 . 8 4-74
11 24-hourhigh . 13 8-47 12 11-42 . 11 14-73 10 3 05
Examples of Anomalies
Room 2 Treatment 10 Room 3 Treatment 8
Weeks Obs. Exp. Weeks Obs. Exp.
64-67 2 4-5 . 56-59 6 4-2
68-71 5 4-6 . 60-63 1 4 0
72-75 0 3-7 . 64-67 9 3 9
76-79 11 33-2 68-71 3 3-4
80-83 3 2-5 . -
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Table XI gives the means over four rooms of the three lognormal distribution
parameters. The same analysis of variance as for rates, but without transforma-
tion, was done on the three parameters. Itwasfoundthatthestandarddeviation s
did not significantly change from one treatment to another or between dose levels.
In Tables XII and XIII have been extracted the mean tumour-induction times for
the three dose rates and for the three treatments.
TABLE XII.-Me,ans ofLognormal Distributions
Infiltrating
Tumours Carcinomas carcinomas
log weeks log weeks log weeks
Low dose . 4-913 136 . 5-042 155 . 5-469 238
Medium dose . 4-640 103 4-817 124 . 5-066 159
High dose . 4445 85 . 4-637 102 . 4-734 114
C.L. (p = 0 95) . 0 053 0-090 . 0 176 -
X2 dose effect .
C.L. (p = 0-95)
0-234 - . 0 203 . 0-367
0 038 - . 0-064 - . 0-124
TABLE XI1I.-Jlean8 ofLognormal Distribution8
Tumours
log weeks
Neutral fraction . 4-731 114 .
Stored condensate . 4-709 110 .
24-hr. condensate . 4-558 95 .
C.L. (p = O* 95) . 0-053
Mean . . 4-666
Carcinomas
C- -- CA-----
log weeks
4- 888 137
4-863 135
4 745 104
-. 0090
4- 832
Infiltrating
carcinomas
log weeks
5- 206 156
5-132 152
4 930 139
. 0-176
. 5- 089
The fall of the mean tumour-induction time as the dose increases is not sig-
nificantly different from a linear change (in the log time); and the differences in
the rate of change between the three tumour responses are not significant, the
average fall for a doubled dose being 0-235 ± 0-031 or about 270/%.
The three types ofcondensate show the same pattern in all three responses with
stored condensate having a mean a little below that of neutral fraction (0.024 or
3%) and 24-hour old condensate appreciably lower (0-177 or 19%). The means
differ significantly for the three tumour responses in the order all tumours (lowest),
carcinomas, and infiltrating carcinomas (highest). The stored condensate anomaly
and the similarity of 24-hour condensate high and 24-hour condensate medium
dose rates can still be seen but they are not significant. For the proportion of
animals which would never develop tumours (c) the difference between treatments
are consistent, showing a fall of about 1% between neutral fraction and stored
condensate and about 7% between neutral fraction and 24-hour condensate. The
stored condensate anomaly is significant only in the analysis of c for all tumours.
MEASUREMENT OF TUMORIGENICITY
There are many response scales which can be used to measure tumorigenicity
for example tumour rates at different times in the experiment. These scales will
give different ratios for the relative response of two substances as shown in Table
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IX. In many cases however the response ratio for two substances varies from
scale in the same way as the response to different doses of a single substance. A
dose level of one substance can be found which would give the same response in
every scale as a known dose of a second substance. Relative tumorigenicity can
then be defined as a dose ratio rather than a response ratio, in a way analogous to
LD 50 in toxicity trials. Toxicity trials are however simpler than carcinogen
assays because they usually last a relatively short time, while the carcinogen
assays must cover nearly the whole life span of the test animals, and it must be
shown that a relative tumorigenicity does not change with time during the trial.
To fulfil this requirement the response-time curves for different substances
must have the same shape (though they may vary both in magnitude of response
and in time of appearance of tumours). The condition for making valid compari-
sons of tumorigenicity may be defined:
The relative tumorigenicitv of two substances is r if, and only if, a dose
D of one produces the same distribution of tumour incidence as a dose rD of
the second, when these doses are administered in the same wav to random
samples of a single population of animals.
This definition implies that in many cases it will not be possible to define a
relative tumorigenicitv because the shapes of distributions of incidence are not
sufficiently similar.
In the present work this type of comparison was justified by showing that the
time-response curves for individual treatments all fitted the lognormal distribu-
tions, so that all the information could be concentrated into the three parameters
m. s and c, which proved to be highly correlated over the population of 44 groups
of mice and three responses. Either m or c could therefore be considered as a
single response parameter permitting a valid measurement of " relative tumori-
genicity " to be made for the three treatments.
As a check on the fit of this model, graphs of the tumorigenic force T were
prepared. These all showed that T increased with time; but when straight lines
were fitted, allowing for the decreasing weight ofthe observations as the number of
animals falls, it was found that the slopes were proportional to the mean, so that
the condition was fulfilled. The similarity is shown by Fig. 7, in which the
uncorrected number oftumour-bearing animals for neutral fraction high dose has
been matched by interpolating between 24-hour condensate medium and low doses.
The analysis of variance of the tumour-induction time m or proportion of
animals which never develop tumours c canthen be used to interpolate between the
responses for different dose levels to get relative carcinogenicities for different
smoke condensates and Fisher's method can be used to obtain fiducial limits for
the ratios (Fisher, 1946). No difference was found between the results (Table A'
above) obtained with either parameter or those for all tumours, carcinomas and
infiltrating carcinomas and the mean ratios of carcinogenicity are given in Table
IV. This similarity ofthe curves obtained for the different condensates and types
of tumour suggests that the mechanism of tumour production is the same for all
three types of condensate.
The use ofratios obtained using the lognormal model depends of course on the
assumptions:
(a) The model is realistic and since the tests of fit are not unsatisfactory the
parameters obtained do in fact represent the data.
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(b) The division of information shown by the analysis of variance, with dose
response relationship in m and c and random variations in s has not in fact
destroyed relevant information on dose response relationships.
If either of these assumptions has to be rejected the results must be expressed
using incidence rate measures of response, as in the right-hand side of Table IV.
CONCLUSIONS
Two important conclusions of interest to statisticians can be drawn from this
experiment.
1. In tests of weak carcinogens where it is essential to use the maximum pos-
sible dose, and to continue treatment until death, there will often be dif-
ferences in mortality between dose levels and treatments. It is important
to allow for this in the analysis of the results, if it is possible to make the
basic assumptions so that correction is possible.
2. The lognormal distribution of tumorigenic force, with some animals never
developing tumours, fits the data from this experiment. It provides a
simpler picture than the other analyses which have been done.
REFERENCES
BARTLETT, M. S. (1947) Biometrics, 3, 39.
BENTLEY, H. R. AND BURGAN, J. G.-(1961) 'Cigarette smoke condensate: preparation
and routine laboratory estimation'. 2nd edition. London (Tobacco Manu-
facturers' Standing Committee) Research Paper No. 4.CIGARETTE SMOKE CONDENSATE 81
BLANDING, F. H., KING, W. H. JR., PRIESTLEY, W. JR., AND REHNER, J. JR.-(1951)
Archs ind. Hyg., 4, 335.
BOAG, J. W.-(1948) Br. J. Radiol., 21, 128 and 189.-(1949) Jl R. statist. Soc., B., 11, 15.
BRYAN, W. R. AND SHIMKIN, N. B.-(1941) J. natn. Cancer Inst., 1, 807.
DAY, T. D.-(1961) Rep. Br. Emp. Cancer Campn, 39, 452.
FISHER, R. A.-(1946) ' Statistical Methods for Research Workers ' 10th edition.
Edinburgh (Oliver & Boyd) p. 142.
IRWIN, J. 0. AND GOODMAN, N.-(1946) J. Hyg., Camb., 44, 362.
LAURENE, A. H. AND HARRELL, T. G.-(1958) Analyt. Chem., 30, 1800.
LEA, D. E.-(1945) Cancer Res., 5, 633.
NELDER, J. A. AND MEAD, R.-(1965) Comput. J., 7, 308.
PALMES, E. D., ORRIS, L. AND NELSON, N.-(1962) Am. ind. Hyg. Ass. J., 23, 257.
TWORT, C. C. AND TWORT, J. M.-(1933) Am. J. Cancer, 17, 293.
WILLITS, C. O., SWAIN, M. L. AND CONNELLY, J. A.-(1950) Analyt. Chem., 22, 430.
WYNDER, E. L., GRAHAM, E. A. AND CRONINGER, A. B.-(1955) Cancer Res., 15, 445.
WYNDER, E. L. AND HOFFMANN, D.-(1959) Cancer, N.Y., 12, 1079. (1964) Adv.
Cancer Res., 8, 250.
YULE, G. U.-(1934) Jl R. statist. Soc., 97, 1.